Key Findings Published in Nature Medicine

The research, published in Nature Medicine, identifies hyperuricemia—abnormally high levels of uric acid—as a potential factor contributing to increased mortality and cognitive challenges among children with severe malaria. This insight could lead to enhancements in treatment strategies for this deadly disease.

Hyperuricemia Linked to Severe Outcomes

“Hyperuricemia is strongly associated with death in hospitals and after discharge, and with long-term cognitive impairment in children with severe malaria,” opined Chandy C. John, MD, the Ryan White Professor of Pediatrics at Indiana University School of Medicine, who co-led the study. He added that the study also elucidated mechanisms linking hyperuricemia to these outcomes, suggesting it could be a contributory factor rather than just an association.

Prevalence and Causes of Hyperuricemia

The study analyzed data from two separate groups of children with severe malaria in Uganda and found that 25% exhibited hyperuricemia. Uric acid, a waste product in the blood, can accumulate due to malfunctioning kidneys or the breakdown of infected red blood cells. These conditions hinder the body’s natural uric acid elimination processes.

Specific Negative Impacts of Hyperuricemia

Hyperuricemia was linked to four severe consequences in children with malaria:

• Increased risk of health complications like coma and anemia
• Elevated risk of death during hospitalization
• Higher risk of death post-discharge
• Persistent cognitive impairment in survivors

Gut Bacteria and Sepsis

Children with hyperuricemia in the study had more detrimental gut bacteria populations. These bacteria can penetrate damaged intestinal walls, leading to sepsis. This information underscores the need for clinical trials testing the efficacy of medications that lower uric acid as an adjunct therapy for severe malaria.

Looking Forward

Andrea Conroy, PhD, an associate professor of pediatrics at Indiana University School of Medicine and co-leader of the study, stated, “Future research should investigate whether lowering uric acid in children with severe malaria can reduce hospital and post-discharge fatalities and cognitive impairment.” This hope suggests that these studies could reveal novel treatment insights saving lives.

Broader Context of Malaria

This research builds on recent findings of partial resistance to primary malaria treatments in children in Africa. Both studies emphasize the urgent need for innovative strategies to combat malaria, which affects nearly 263 million individuals and results in around 600,000 deaths globally each year.